Welcome to our dedicated page for Certara news (Ticker: CERT), a resource for investors and traders seeking the latest updates and insights on Certara stock.
Certara Inc (NASDAQ: CERT) operates in the biosimulation software and drug development services sector, making its news particularly relevant for investors tracking pharmaceutical technology trends and regulatory science developments.
As a company serving the biopharmaceutical industry, Certara's news flow typically includes quarterly earnings reports that detail software subscription growth and services revenue, product announcements for platform expansions and new simulation capabilities, and strategic partnerships with pharmaceutical companies and regulatory agencies.
The nature of Certara's business means significant news events often relate to regulatory milestones, such as platform qualifications from the FDA or European Medicines Agency, which validate the company's technology for use in drug approval submissions. These regulatory endorsements can expand the addressable market for Certara's platforms.
Investors following Certara should also monitor announcements regarding customer expansions, particularly deals with large pharmaceutical companies that could indicate growing adoption of biosimulation approaches in drug development. Technology collaborations and acquisitions that expand platform capabilities represent another category of material news for the company.
Bookmark this page to track Certara's earnings releases, product launches, regulatory developments, and strategic announcements that may impact the company's position in the life sciences technology market.
Certara, Inc. reported its first quarter 2024 financial results, with revenue reaching $96.7 million, a 7% increase from the previous year. Software revenue grew by 19% to $39.3 million, while services revenue remained flat. The net loss was $4.7 million, with adjusted EBITDA at $29.1 million. The company reiterated its full-year 2024 financial guidance, expecting revenue between $385 million to $400 million.
FAQ
What is the current stock price of Certara (CERT)?
What is the market cap of Certara (CERT)?
